ZD Stock Analysis: Ziff Davis | NASDAQ
Advertising Agencies | NASDAQ, USA | Market Cap: 1.922m USD | 12M Return: 59.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 34.0M
EPS Trend: 70.6%
Qual. Beats: 0
Rev. Trend: 76.0%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ziff Davis, Inc. is a digital media and internet company headquartered in New York that operates a diversified portfolio of consumer-facing and business-to-business brands across multiple verticals. Its segments include technology reviews and news (PCMag, CNET, Mashable), coupons and deals (RetailMeNot, VoucherCodes, Offers.com, BlackFriday.com), gaming and entertainment (IGN Entertainment, Humble Bundle), internet connectivity analytics (Speedtest/Ookla, Downdetector, RootMetrics), health and wellness content (Everyday Health, BabyCenter, What to Expect, Lose It!), medical education for healthcare professionals (PRIME Education, Health eCareers), cybersecurity and privacy (IPVanish, VIPRE, SugarSync), and digital marketing tools (Campaigner, iContact, MOZ, eVoice).
Within the Application Software sub-industry, Ziff Davis generates revenue primarily through digital advertising, affiliate commissions from e-commerce referrals, subscription-based software services, and licensing of its connectivity and analytics tools. The companys business model relies on a multi-brand strategy, acquiring and operating specialized digital properties to monetize audiences through targeted advertising and recurring software subscriptions. The company was formerly known as j2 Global, Inc. before rebranding to Ziff Davis in October 2021.
- Affiliate commerce revenue pressured by weak digital ad spend
- Cybersecurity subscriptions drive recurring revenue growth
- Health and wellness ad demand softens amid macro headwinds
| Net Income: 45.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.96 > 1.0 |
| NWC/Revenue: 41.13% < 20% (prev 25.96%; Δ 15.17% < -1%) |
| CFO/TA 0.12 > 3% & CFO 416.4m > Net Income 45.4m |
| Net Debt (403.5m) to EBITDA (306.4m): 1.32 < 3 |
| Current Ratio: 1.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (37.6m) vs 12m ago -14.88% < -2% |
| Gross Margin: 73.81% > 18% (prev 86.02%; Δ -12.21% > 0.5%) |
| Asset Turnover: 40.24% > 50% (prev 40.27%; Δ -0.03% > 0%) |
| Interest Coverage Ratio: 1.71 > 6 (EBIT TTM 88.7m / Interest Expense TTM 52.0m) |
| A: 0.17 (Total Current Assets 1.44b - Total Current Liabilities 863.7m) / Total Assets 3.39b |
| B: 0.39 (Retained Earnings 1.33b / Total Assets 3.39b) |
| C: 0.03 (EBIT TTM 88.7m / Avg Total Assets 3.46b) |
| D: 1.03 (Book Value of Equity 1.72b / Total Liabilities 1.67b) |
| Altman-Z'' = 3.64 = AA |
| DSRI: 0.78 (Receivables 397.5m/517.9m, Revenue 1.39b/1.42b) |
| GMI: 1.17 (GM 86.02% / 73.81%) |
| AQI: 0.83 (AQ_t 0.53 / AQ_t-1 0.64) |
| SGI: 0.98 (Revenue 1.39b / 1.42b) |
| TATA: -0.11 (NI 45.4m - CFO 416.4m) / TA 3.39b) |
| Beneish M = -3.18 (Cap -4..+1) = AA |
As of July 15, 2026, the stock is trading at USD 51.94 with a total of 515,557 shares traded. Over the past week, the price has changed by -2.48%, over one month by +13.28%, over three months by +13.85% and over the past year by +59.47%.
Current recommended Stop Loss: 47.70 (which is 8.2% or 2.3 ATR below the current price).
Ziff Davis has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold ZD.
- StrongBuy: 2
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 49.4 | -4.9% |
P/E Trailing = 44.5983
P/E Forward = 9.6805
P/S = 1.3291
P/B = 1.1165
P/EG = 1.5248
Revenue TTM = 1.39b USD
EBIT TTM = 88.7m USD
EBITDA TTM = 306.4m USD
Long Term Debt = 718.3m USD (from longTermDebt, last quarter)
Short Term Debt = 148.8m USD (from shortTermDebt, last quarter)
Debt = 923.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 56.1m
Net Debt = 403.5m USD (calculated: Debt 923.2m - CCE 519.7m)
Enterprise Value = 2.33b USD (1.92b + Debt 923.2m - CCE 519.7m)
Interest Coverage Ratio = 1.71 (Ebit TTM 88.7m / Interest Expense TTM 52.0m)
EV/FCF = 8.03x (Enterprise Value 2.33b / FCF TTM 289.7m)
FCF Yield = 12.46% (FCF TTM 289.7m / Enterprise Value 2.33b)
FCF Margin = 20.84% (FCF TTM 289.7m / Revenue TTM 1.39b)
Net Margin = 3.26% (Net Income TTM 45.4m / Revenue TTM 1.39b)
Gross Margin = 73.81% ((Revenue TTM 1.39b - Cost of Revenue TTM 364.1m) / Revenue TTM)
Gross Margin QoQ = 66.67% (prev 71.69%)
Tobins Q-Ratio = 0.69 (Enterprise Value 2.33b / Total Assets 3.39b)
Interest Expense / Debt = 5.63% (Interest Expense 52.0m / Debt 923.2m)
Taxrate = 46.60% (19.5m / 41.8m)
NOPAT = 47.4m (EBIT 88.7m * (1 - 46.60%))
Current Ratio = 1.66 (Total Current Assets 1.44b / Total Current Liabilities 863.7m)
Debt / Equity = 0.54 (Debt 923.2m / totalStockholderEquity, last quarter 1.72b)
Debt / EBITDA = 1.32 (Net Debt 403.5m / EBITDA 306.4m)
Debt / FCF = 1.39 (Net Debt 403.5m / FCF TTM 289.7m)
Total Stockholder Equity = 1.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.31% (Net Income 45.4m / Total Assets 3.39b)
RoE = 2.55% (Net Income TTM 45.4m / Total Stockholder Equity 1.78b)
RoCE = 3.55% (EBIT 88.7m / Capital Employed (Equity 1.78b + L.T.Debt 718.3m))
RoIC = 1.81% (NOPAT 47.4m / Invested Capital 2.61b)
WACC = 7.64% (E(1.92b)/V(2.85b) * Re(9.86%) + D(923.2m)/V(2.85b) * Rd(5.63%) * (1-Tc(0.47)))
Discount Rate = 9.86% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -90.71 | Cagr: -12.66%
[DCF] Terminal Value 77.97% ; FCFF base≈266.3m ; Y1≈305.3m ; Y5≈449.3m
[DCF] Fair Price = 172.6 (EV 6.76b - Net Debt 403.5m = Equity 6.36b / Shares 36.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 70.62 | EPS CAGR: 2.61% | SUE: -0.38 | # QB: 0
Revenue Correlation: 76.00 | Revenue CAGR: 2.14% | SUE: 0.34 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.86 | Chg30d=+4.27% | Revisions=-17% | Analysts=3
EPS next Quarter (2026-09-30): EPS=1.42 | Chg30d=+2.22% | Revisions=-17% | Analysts=3
EPS current Year (2026-12-31): EPS=5.18 | Chg30d=+1.16% | Revisions=+0% | GrowthEPS=-21.8% | GrowthRev=-16.2%
EPS next Year (2027-12-31): EPS=5.69 | Chg30d=+2.22% | Revisions=+29% | GrowthEPS=+9.8% | GrowthRev=+1.5%
[Analyst] Revisions Ratio: +0% (up=7, down=7)